![Oliver von Stein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver von Stein
Amministratore Delegato presso
Berlin Cures Holding AG
Profilo
Oliver von Stein currently works at Berlin Cures Holding AG, as Chief Executive Officer & Director from 2024 and Berlin Cures GmbH, as Chief Executive Officer.
Dr. von Stein also formerly worked at Silence Therapeutics Plc, as Operations Director from 2014 to 2015, MediGene AG, as Project Leader, and Flerie AB, as Chief Scientific Officer.
Dr. von Stein received his doctorate degree from Karlsruher Institut für Technologie.
Posizioni attive di Oliver von Stein
| Società | Posizione | Inizio |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Amministratore Delegato | 15/06/2023 |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Amministratore Delegato | - |
Precedenti posizioni note di Oliver von Stein
| Società | Posizione | Fine |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Direttore operativo | 01/08/2015 |
| MEDIGENE AG | Corporate Officer/Principal | - |
| FLERIE INVEST AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Oliver von Stein
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Karlsruher Institut für Technologie
 Karlsruher Institut für Technologie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
